Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure
Banzato Marco, Colognesi Martina, Lucatello Lorena, Comai Stefano, Pasut Gianfranco, Capolongo Francesca, Orian Laura, Biasutto Lucia, Signor Anna, Gabbia Daniela, Manfredi Paolo L., De Martin Sara, Mattarei Andrea
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (80)
- Emerging mechanisms of psilocybin-induced neuroplasticity. 2025-11-01 · Expand citations
- Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans 2025-04-21 · Expand citations
- Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic Properties 2025-04-10 · Expand citations
- Pharmacokinetics of Psilocybin: A Systematic Review. 2025-03-25 · Expand citations
- Less is more? A review of psilocybin microdosing. 2024-10-01 · Expand citations
- In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin 2024-04-29 · Expand citations
- In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin 2024-01-08 · Expand citations
- The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov. 2024-01-01 · Expand citations
- Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats. 2023-09-01 · Expand citations
- Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy. 2023-08-01 · Expand citations
- Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. 2023-06-01 · Expand citations
- Microdosing psilocybin for chronic pain: a case series. 2023-04-01 · Expand citations
- The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics. 2023-01-01 · Expand citations
- Towards an understanding of psychedelic-induced neuroplasticity. 2023-01-01 · Expand citations
- Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. 2022-08-02 · Expand citations
- The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field. 2022-08-01 · Expand citations
- Trial of Psilocybin versus Escitalopram for Depression. 2021-04-15 · Expand citations
- Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin. 2021-04-01 · Expand citations
- Emotions and brain function are altered up to one month after a single high dose of psilocybin. 2020-02-10 · Expand citations
- An Improved, Practical, and Scalable Five-Step Synthesis of Psilocybin 2020-01-08 · Expand citations
- Microdosing psychedelics: More questions than answers? An overview and suggestions for future research. 2019-09-01 · Expand citations
- Motives and Side-Effects of Microdosing With Psychedelics Among Users. 2019-07-01 · Expand citations
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels 2019-06-01 · Expand citations
- Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. 2019-02-01 · Expand citations
- Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration. 2019-01-01 · Expand citations
- Psychiatry & the psychedelic drugs. Past, present & future. 2018-11-01 · Expand citations
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. 2018-02-01 · Expand citations
- Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression. 2018-02-01 · Expand citations
- Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults. 2017-12-01 · Expand citations
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
- Psychedelics. 2016-04-01 · Expand citations
- Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
- Concise Large-Scale Synthesis of Psilocin and Psilocybin, Principal Hallucinogenic Constituents of “Magic Mushroom” 2003-06-01 · Expand citations
- Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man 2002-09-01 · Expand citations
- Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin 1999-06-01 · Expand citations
- Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man 1997-06-01 · Expand citations
- Comparison of solution conformational preferences for the hallucinogens bufotenin and psilocin using 360-MHz proton NMR spectroscopy 1981-02-01 · Expand citations
- 10.1002/adhm.202301650
- 10.1002/jcc.1056
- 10.1002/jcc.21759
- 10.1002/wcms.1218
- 10.1007/s00213-013-3006-z
- 10.1007/s00213-018-5049-7
- 10.1007/s00213-018-5119-x
- 10.1007/s002140050353
- 10.1007/s10862-006-9035-8
- 10.1016/j.biopsych.2019.05.019
- 10.1016/j.bpsc.2019.12.007
- 10.1016/j.brainresbull.2016.04.016
- 10.1016/j.celrep.2018.05.022
- 10.1016/j.ejpb.2017.02.017
- 10.1016/j.jconrel.2021.11.006
- 10.1016/j.neubiorev.2017.03.007
- 10.1016/j.phrs.2025.108080
- 10.1016/j.vascn.2025.107622
- 10.1021/acs.jmedchem.3c01225
- 10.1021/acs.molpharmaceut.5b00464
- 10.1021/cr60237a002
- 10.1021/jm990968+
- 10.1038/s41386-023-01772-4
- 10.1038/s41392-023-01481-w
- 10.1038/s41598-019-49913-4
- 10.1038/sj.npp.1301564
- 10.1038/srep15216
- 10.1039/c8cp05922e
- 10.1063/1.2065267
- 10.1063/1.2139668
- 10.1103/physreva.38.3098
- 10.1103/physrevb.37.785
- 10.1126/science.adf0435
- 10.1155/2017/6871089
- 10.1155/2020/4245821
- 10.1177/1455072517753339
- 10.1177/20451253231198466
- 10.1186/s12954-021-00489-1
- 10.1371/journal.pone.0211023
- 10.31887/dcns.2009.11.3/cpobrien
- 10.3390/ijms24097754
- 10.3892/etm.2021.10565
Cited by — these papers cite this paper (0)
No citing papers identified in the available metadata. This does not establish that none exist.